The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Challenges in MRD measurement by multiparameter flow cytometry in AML

Sep 15, 2020

The virtual AML Hub Satellite Symposiumat the 46 thAnnual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) brought together an international panel of expertsto discuss how measurable residual disease (MRD) impacts outcome of stem cell transplantation in AML, now and in the future. Professor Jacqueline Cloos, Amsterdam University Medical Center, Amsterdam, NL, presented the topic ‘Challenges in MRD measurement by multiparameter flow cytometry in AML.’

Following a brief overview of the techniques used to assess MRD in AML, Professor Jacqueline Cloos focuses her presentation on the technical aspects of multiparameter flow cytometry, one of the most commonly used methods for MRD detection. She describes the different approaches for multiparameter flow cytometry MRD assessment and the limitations of this technique. She also reports on the European LeukemiaNet (ELN) Working Party recommendations for MRD measurement by multiparameter flow cytometry in AML.

The first AML Hub Satellite Symposium: Watch here!

Welcome to the AML Hub Satellite Symposium.

Please take a moment to complete the survey and answer the following question to help us gauge your current understanding of MRD assessment by flow cytometry in AML.